ARCEDE PHARMA AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1005 SEK | +2.55% |
|
+11.92% | +10.44% |
| 2023 | Arcede Pharma Announces CEO Changes | CI |
| 2023 | Arcede Pharma and Iconovo AB Takes the Next Step in the Development of a New Treatment for COPD | CI |
Sales per Business
| SEK in Million | 2023 | Weight | Delta |
|---|---|---|---|
Drug Development for Chronic Obstructive Pulmonary Disease and Severe Asthma
100.0
%
| 0 | 100.0 % | - |
Sales per region
| SEK in Million | 2023 | Weight | Delta |
|---|---|---|---|
Sweden
100.0
%
| 0 | 100.0 % | - |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Erik Magnusson
CEO | Chief Executive Officer | 63 | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | - | |
Johanna Asklin
BRD | Director/Board Member | 47 | 01/22/01 |
Laurent Pacheco
BRD | Director/Board Member | 48 | 01/22/01 |
Åsa Kornfeld
BRD | Director/Board Member | - | 01/22/01 |
| 50 | - |
Company contact information
Arcede Pharma AB
Scheeletorget 1 Medicon Village
223 81, Lund
+46 7 23 12 27 44
http://www.arcedepharma.com
Sector
This company's sector is not yet available
- Stock Market
- Equities
- ARCEDE Stock
- Company Arcede Pharma AB
